Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7.61M | $63.0M | 11.65% | +811.5K | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.12M | $34.0M | 6.31% | +233.8K | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 3.50M | $29.0M | 5.35% | -143.4K | 2026-06-30 |
| Pfizer Inc | 3.46M | $27.0M | 5.30% | -- | 2026-06-30 |
| ARMISTICE CAPITAL, LLC | 2.80M | $23.0M | 4.28% | +818.0K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.71M | $22.0M | 4.16% | +24.8K | 2026-06-30 |
| TWO SIGMA INVESTMENTS, LP | 2.57M | $21.0M | 3.94% | -- | 2026-06-30 |
| STATE STREET CORP | 2.20M | $18.0M | 3.36% | +368.4K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.67M | $13.0M | 2.55% | +110.2K | 2026-06-30 |
| Qube Research & Technologies Ltd | 1.59M | $13.0M | 2.44% | +390.6K | 2026-06-30 |
